Viewing Study NCT07066995


Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2025-12-27 @ 9:38 PM
Study NCT ID: NCT07066995
Status: RECRUITING
Last Update Posted: 2025-07-15
First Post: 2025-07-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Sponsor: Essen Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module